These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 1984460

  • 21. Effect of different forms of adenylate cyclase toxin of Bordetella pertussis on protection afforded by an acellular pertussis vaccine in a murine model.
    Cheung GY, Xing D, Prior S, Corbel MJ, Parton R, Coote JG.
    Infect Immun; 2006 Dec; 74(12):6797-805. PubMed ID: 16982827
    [Abstract] [Full Text] [Related]

  • 22. Serologic diagnosis of pertussis: evaluation of pertussis toxin and other antigens in enzyme-linked immunosorbent assay.
    Mertsola J, Ruuskanen O, Kuronen T, Meurman O, Viljanen MK.
    J Infect Dis; 1990 May; 161(5):966-71. PubMed ID: 2324547
    [Abstract] [Full Text] [Related]

  • 23. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group.
    Greco D, Salmaso S, Mastrantonio P, Giuliano M, Tozzi AE, Anemona A, Ciofi degli Atti ML, Giammanco A, Panei P, Blackwelder WC, Klein DL, Wassilak SG.
    N Engl J Med; 1996 Feb 08; 334(6):341-8. PubMed ID: 8538704
    [Abstract] [Full Text] [Related]

  • 24. Antibody responses after vaccination and disease against leukocytosis promoting factor, filamentous hemagglutinin, lipopolysaccharide and a protein binding to complement-fixing antibodies induced during whooping cough.
    Winsnes R, Lønnes T, Møgster B, Berdal BP.
    Dev Biol Stand; 1985 Feb 08; 61():353-65. PubMed ID: 2872124
    [Abstract] [Full Text] [Related]

  • 25. Bioengineering of Bordetella pertussis Adenylate Cyclase Toxin for Vaccine Development and Other Biotechnological Purposes.
    Ladant D.
    Toxins (Basel); 2021 Jan 22; 13(2):. PubMed ID: 33499260
    [Abstract] [Full Text] [Related]

  • 26. Cell-mediated immunity and antibody responses to Bordetella pertussis antigens in children with a history of pertussis infection and in recipients of an acellular pertussis vaccine.
    Ausiello CM, Lande R, Urbani F, Di Carlo B, Stefanelli P, Salmaso S, Mastrantonio P, Cassone A.
    J Infect Dis; 2000 Jun 22; 181(6):1989-95. PubMed ID: 10837180
    [Abstract] [Full Text] [Related]

  • 27. Immunoelectron microscopy of antigens of Bordetella pertussis using monoclonal antibodies to agglutinogens 2 and 3, filamentous haemagglutinin, pertussis toxin, pertactin and adenylate cyclase toxin.
    Blom J, Heron I, Hendley JO.
    APMIS; 1994 Sep 22; 102(9):681-9. PubMed ID: 7946271
    [Abstract] [Full Text] [Related]

  • 28. Antibody responses to defined regions of the Bordetella pertussis virulence factor pertactin.
    Hijnen M, He Q, Schepp R, Van Gageldonk P, Mertsola J, Mooi FR, Berbers GA.
    Scand J Infect Dis; 2008 Sep 22; 40(2):94-104. PubMed ID: 17926203
    [Abstract] [Full Text] [Related]

  • 29. Epitope mapping of monoclonal antibodies against Bordetella pertussis adenylate cyclase toxin.
    Lee SJ, Gray MC, Guo L, Sebo P, Hewlett EL.
    Infect Immun; 1999 May 22; 67(5):2090-5. PubMed ID: 10225859
    [Abstract] [Full Text] [Related]

  • 30. Impaired long-term maintenance and function of Bordetella pertussis specific B cell memory.
    Stenger RM, Smits M, Kuipers B, van Gaans-van den Brink J, Poelen M, Boog CJ, van Els CA.
    Vaccine; 2010 Sep 14; 28(40):6637-46. PubMed ID: 20637762
    [Abstract] [Full Text] [Related]

  • 31. Safety and immunogenicity of two acellular pertussis vaccines with different pertussis toxoid and filamentous hemagglutinin content in infants 2-6 months old.
    Halperin SA, Eastwood B, Barreto L, Mills E, Blatter M, Reisinger K, Bader G, Keyserling H, Roberts EA, Guasparini R.
    Scand J Infect Dis; 1995 Sep 14; 27(3):279-87. PubMed ID: 8539554
    [Abstract] [Full Text] [Related]

  • 32. Crucial role of antibodies to pertactin in Bordetella pertussis immunity.
    Hellwig SM, Rodriguez ME, Berbers GA, van de Winkel JG, Mooi FR.
    J Infect Dis; 2003 Sep 01; 188(5):738-42. PubMed ID: 12934190
    [Abstract] [Full Text] [Related]

  • 33. Evaluation of pooled and individual components of Bordetella pertussis as antigens in an enzyme immunoassay for diagnosis of pertussis.
    He Q, Mertsola J, Himanen JP, Ruuskanen O, Viljanen MK.
    Eur J Clin Microbiol Infect Dis; 1993 Sep 01; 12(9):690-5. PubMed ID: 8243485
    [Abstract] [Full Text] [Related]

  • 34. A randomized comparison of reactogenicity and immunogenicity of two whole-cell pertussis vaccines.
    Steinhoff MC, Reed GF, Decker MD, Edwards KM, Englund JA, Pichichero ME, Rennels MB, Anderson EL, Deloria MA, Meade BD.
    Pediatrics; 1995 Sep 01; 96(3 Pt 2):567-70. PubMed ID: 7659477
    [Abstract] [Full Text] [Related]

  • 35. [Application of DNA microcarriers for evaluation of mice splenocytes genes expression after immunization with pertussis vaccines and challenged with different B. pertussis strains].
    Gzyl A, Woyciechowska-Oczko M, Jarzab B, Augustynowicz E, Mosiej E, Slusarczyk J.
    Med Dosw Mikrobiol; 2007 Sep 01; 59(2):149-59. PubMed ID: 17929412
    [Abstract] [Full Text] [Related]

  • 36. Blockade of the Adenylate Cyclase Toxin Synergizes with Opsonizing Antibodies to Protect Mice against Bordetella pertussis.
    DiVenere AM, Amengor D, Silva RP, Goldsmith JA, McLellan JS, Maynard JA.
    mBio; 2022 Aug 30; 13(4):e0152722. PubMed ID: 35920558
    [Abstract] [Full Text] [Related]

  • 37. Development and validation of a multiplex immunoassay for the simultaneous determination of serum antibodies to Bordetella pertussis, diphtheria and tetanus.
    van Gageldonk PG, van Schaijk FG, van der Klis FR, Berbers GA.
    J Immunol Methods; 2008 Jun 01; 335(1-2):79-89. PubMed ID: 18407287
    [Abstract] [Full Text] [Related]

  • 38. Pertussis toxin and extracytoplasmic adenylate cyclase as virulence factors of Bordetella pertussis.
    Weiss AA, Hewlett EL, Myers GA, Falkow S.
    J Infect Dis; 1984 Aug 01; 150(2):219-22. PubMed ID: 6088647
    [Abstract] [Full Text] [Related]

  • 39. [Analysis of chosen parameters of immuno response in mice immunized with whole-cell or acellular pertussis vaccines and challenged with B. pertussis strains harbouring different ptxS1/prn allele genes combinations].
    Gzyl A, Augustynowicz E, Zawadka M, Rabczenko D, Slusarczyk J.
    Med Dosw Mikrobiol; 2007 Aug 01; 59(2):137-47. PubMed ID: 17929411
    [Abstract] [Full Text] [Related]

  • 40. [Immune response to various antigenic preparations of Bordetella pertussis in whooping cough patients and convalescents studied by immunoenzyme analysis].
    Tsvetkova NV, Borisenko IuV, Selezneva TS, Baeva EA.
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Oct 01; (10):53-6. PubMed ID: 2879403
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.